YOLFTbeta
Huons Global Co. Ltd

Huons Global Co. Ltd

084110 · KQ · Healthcare / Pharmaceuticals

19,430.00KRW+10.00 (+0.05%)

Price History

Full chart

Market Stats

Previous Close19,420.00
Open19,470.00
Day Range19,050.00 – 19,740.00
52-Week Range19,839.81 – 75,041.23
Volume24.34K
Market Cap275.89B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.54%
Beta1.29
50-Day Avg23,584.00
200-Day Avg41,531.50

About

Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and others, as well as circulatory, respiratory, and other tissue cell systems. It also provides medical devices, eye drop products, and bio products. The company was formerly known as Huons Co., Ltd. and changed its name to Huons Global Co., Ltd. in June 2016. Huons Global Co., Ltd. was founded in 1965 and is headquartered in Seongnam, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Yong-Seung Lee
  • Employees0
  • Headquarters253C-902 Pangyo-ro, Seongnam-si, South Korea, 13486, Korea
  • Websitehttps://www.huons.com

Leadership

  • Mr. Yong-Seung LeeManaging Director · b. 1966
  • Hyeon-Suk YuSr. Managing Director · b. 1959
  • Jeong-Hun KimManaging Director · b. 1962
  • Yun-Bae KimManaging Director · b. 1959
  • Su-Il YeomManaging Director · b. 1961
  • Byeong-Don ChoiManaging Director · b. 1970
  • Mr. Bo-Young YoonVice-Pres and Director · b. 1965

Financials

Income Statement

Currency: KRW2010-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue94.13B135.51B158.18B182.34B65.45B163.71B323.96B378.69B449.42B523.05B574.65B664.36B758.38B813.46B847.45B
Growth (%)-+43.96%+16.73%+15.27%-64.11%+150.14%+97.88%+16.89%+18.68%+16.38%+9.87%+15.61%+14.15%+7.26%+4.18%
Cost of Revenue40.64B62.56B71.70B78.11B37.20B75.06B128.35B154.92B193.23B231.97B251.27B298.74B340.17B393.05B436.56B
Gross Profit---94.24B28.25B88.65B195.62B223.76B256.19B291.08B323.38B365.63B418.21B420.41B410.89B
Gross Margin---51.68%43.16%54.15%60.38%59.09%57.00%55.65%56.27%55.03%55.15%51.68%48.49%
Operating Expense---64.14B16.21B63.70B133.40B150.84B185.38B202.35B273.05B354.10B299.88B334.33B320.15B
Operating Income-14.83B27.94B30.10B12.04B24.95B62.21B72.92B70.82B88.73B50.33B11.53B118.33B86.08B90.75B
Operating Margin-10.94%17.66%16.51%18.40%15.24%19.20%19.26%15.76%16.96%8.76%1.74%15.60%10.58%10.71%
EBITDA-----------47.06B167.61B141.15B163.85B
EBITDA Margin-----------7.08%22.10%17.35%19.33%
Net Income-6.67B17.38B20.93B32.38B514.64B25.65B29.45B26.66B42.70B3.99B-60.25B38.38B25.79B28.84B
Net Income Margin-4.92%10.99%11.48%49.48%314.36%7.92%7.78%5.93%8.16%0.70%-9.07%5.06%3.17%3.40%
R&D--10.97B12.67B4.24B13.47B26.90B28.60B34.46B38.43B45.81B52.54B59.59B65.76B66.88B
R&D as % of Total Revenue--6.93%6.95%6.48%8.23%8.30%7.55%7.67%7.35%7.97%7.91%7.86%8.08%7.89%
Interest Expense0000000002.91B7.13B12.76B11.99B10.47B12.52B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.56%1.24%1.92%1.58%1.29%1.48%

Balance Sheet

Currency: KRW2010-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets141.76B185.52B206.22B254.51B314.13B557.06B610.15B672.88B742.15B949.02B1.28T1.24T1.32T1.41T1.56T
Total Liabilities63.58B92.60B80.99B66.14B145.19B237.26B269.00B310.66B363.63B536.19B745.91B778.79B407.29B885.84B468.69B
Total Equity76.13B88.32B114.55B152.93B168.94B319.80B341.14B362.21B378.53B412.83B537.84B464.32B501.83B520.11B546.71B
Cash2.55B21.24B19.37B46.93B79.33B91.08B82.25B69.42B73.34B89.26B1.02M23.23M241.67B15.63M193.20B
Total Debt---------176.46B-----
Net Debt---------73.72B22.20B--45.48B109.56B

Cash Flow

Currency: KRW2010-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow6.68B17.89B24.77B28.79B50.91B19.38B47.52B53.42B65.55B90.59B49.82B63.04B99.97B100.57B93.61B
Investing Cash Flow----23.31B-25.63B-18.22B-57.78B-63.50B-55.97B-166.18B-129.09B6.95B-63.46B-131.50B-
Financing Cash Flow1.53B3.97B-22.03B6.94B10.48B1.58B-2.87B-5.85B111.96B187.62B-6.25B-77.31B32.31B-
Capital Expenditure8.12B10.40B18.13B10.43B11.41B30.57B45.23B52.64B35.33B64.13B144.45B75.91B79.77B133.77B51.87B
Free Cash Flow---------25.83B-96.11B-11.89B18.96B-35.14B41.73B
Dividends Paid335.24M983.00M1.38B2.11B4.52B7.74B6.38B10.11B12.10B11.24B10.12B11.84B19.48B15.60B25.61B
FCF to OCF---------28.52%-192.90%-18.87%18.97%-34.94%44.59%
Dividend Paid to FCF---------43.51%-10.54%-99.59%102.73%-44.38%61.36%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2011May 30, 2012Aug 29, 2012Nov 28, 2012Feb 7, 2013May 31, 2013Aug 12, 2013Nov 13, 2013Feb 16, 2014May 13, 2014Aug 1, 2014Nov 14, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 16, 2016Nov 13, 2016Feb 16, 2017May 31, 2017Aug 13, 2017Nov 12, 2017Feb 28, 2018May 14, 2018Aug 13, 2018Nov 28, 2018Feb 26, 2019May 29, 2019Aug 12, 2019Nov 13, 2019Feb 10, 2020May 13, 2020Aug 18, 2020Nov 11, 2020Feb 8, 2021Jun 2, 2021Aug 17, 2021Nov 17, 2021Feb 7, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Mar 1, 2023May 15, 2023Aug 15, 2023Nov 14, 2023Feb 12, 2024May 13, 2024Aug 14, 2024Nov 14, 2024Mar 20, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------944.72895.00-----------------------------------------------
EPS Actual538.71326.21493.44-48.63-165.51133.6562.07343.35233.97445.26205.79217.61606.34660.24941.95359.67674.88963.371069.03711.38832.891399.701279.891023.481544.0351906.18283.50208.43355.14509.33570.21619.43567.03687.83831.83228.06548.35487.04580.74530.46552.97756.77887.911266.11587.95527.63358.16-1210.13450.21200.88486.88-6063.51547.51642.61903.251040.48893.49832.00216.00166.59918.1332.51882.00528.55499.27-63.64
Surprise-----------------1.97%19.44%-----------------------------------------------
Timing-----------Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-market------Pre-marketAfter-hours--After-hoursAfter-hours-After-hours--Pre-market------------------------------

Key Statistics & Ratios

Market Cap275.89B
Enterprise Value293.69B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.31
Price / Book0.47
Revenue (TTM)659.40B
Gross Profit (TTM)328.25B
EBITDA108.71B
Profit Margin-0.05%
Operating Margin11.53%
Return on Equity502.47%
Return on Assets3.77%
Shares Outstanding10.85M
Shares Float5.09M
Beta1.29
Dividend Yield1.54%
Dividend Rate0.00
Payout Ratio73.12%

Dividends

20263×
400.00Aug 28, 2026200.00May 26, 2026200.00Apr 2, 2026
20254×
550.00Nov 24, 2025130.00Aug 20, 2025275.00Jun 27, 2025250.00Mar 28, 2025
20242×
275.00Jun 27, 2024275.00Mar 29, 2024
20231×
250.00Jun 29, 2023
20221×
500.00Dec 28, 2022
20211×
500.00Dec 29, 2021
20201×
380.95Dec 29, 2020
20191×
362.81Dec 27, 2019
20181×
431.92Dec 27, 2018
20171×
411.35Dec 27, 2017
20161×
313.41Dec 28, 2016
20151×
340.50Dec 29, 2015
20141×
247.64Dec 29, 2014
20131×
123.82Dec 27, 2013
20121×
92.86Dec 27, 2012
20111×
61.91Dec 28, 2011
20101×
61.91Dec 29, 2010
20091×
24.76Dec 29, 2009

Stock Splits

  • Dec 29, 202121:20
  • Dec 29, 202021:20
  • Dec 27, 201921:20
  • Dec 27, 201821:20
  • Dec 27, 201721:20
  • Dec 28, 201651:50
  • Jun 3, 20161895:3926
  • Dec 29, 2009133:129
  • Dec 29, 2008437:430
  • Nov 15, 20072456:2341